BioXcell 热销产品--InVivoPlus rat IgG2a isotype control

产品描述：

BioXcell nVivoPlus rat IgG2a isotype control克隆号为2A3的同型对照抗体与三-硝-基-苯-酚反应。因为哺乳动物不表达三-硝-基-苯-酚，因此该抗体非常适合在大多数体内和体外应用中用作大鼠IgG2a抗体的同型对照。

产品详情：

为什么选择InVivoPlus抗体？

InVivoPlus级别的产品内毒素含量更低，经过多种实验验证，更适合用于体内实验研究

该产品自上市已被多篇SCI文献引用，品质有保证，以下是部分已发表的文献引用：

文章

1.Bauche, D., et al. (2018). 'LAG3(+) Regulatory T Cells Restrain Interleukin-23-Producing CX3CR1(+) Gut-Resident Macrophages during Group 3 Innate Lymphoid Cell-Driven Colitis' Immunity 49(2): 342-352 e345.

2.Ngiow, S. F., et al. (2015). 'A Threshold Level of Intratumor CD8+ T-cell PD1 Expression Dictates Therapeutic Response to Anti-PD1' Cancer Res 75(18): 3800-3811.

3.Dai, M., et al. (2015). 'Curing mice with large tumors by locally delivering combinations of immunomodulatory antibodies' Clin Cancer Res 21(5): 1127-1138.

4.Kurtulus, S., et al. (2015). 'TIGIT predominantly regulates the immune response via regulatory T cells' J Clin Invest. doi : 10.1172/JCI81187.

5.Ellis, G. T., et al. (2015). 'TRAIL+ monocytes and monocyte-related cells cause lung damage and thereby increase susceptibility to influenza-Streptococcus pneumoniae coinfection' EMBO Rep 16(9): 1203-1218.

更多产品详情请联系 BioXcell 中国授权代理——欣博盛生物